Nyeste anskaffelser der leverandøren Seqirus UK Limited nevnes
2022-11-25Enhanced quadrivalent influenza vaccine against seasonal influenza for the 2023/2024 influenza season (Folkehelseinstituttet)
The Norwegian Institute of Public Health (FHI) is inviting tenderers to an open tender for an Enhanced quadrivalent influenza vaccine against seasonal influenza for vaccination of particularly vulnerable persons from 65 years and older (nursing home residents, users of home nursing care, etc.) An enhanced quadrivalent influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups in the national vaccination programme.
The aim is to enter …
Vis anskaffelsen » Nevnte leverandører:Seqirus UK Limited
2022-04-19National vaccine preparedness against pandemic influenza (Folkehelseinstituttet)
The Norwegian Institute of Public Health is carrying out an open tender contest for the procurement of vaccine preparedness against pandemic influenza on behalf of the Ministry of Health and Care Services. The objective of the procurement is to ensure that Norway's residents have access to a vaccine in the event of an influenza pandemic occurring in the contract period.
The procurement shall be carried out as an open tender contest in accordance with the Public Procurement Act Parts 1 and 3. The …
Vis anskaffelsen » Nevnte leverandører:Seqirus UK Limited
2018-01-08Flu pandemic vaccines (Folkehelseinstituttet)
The Norwegian Institute of Public Health (FHI) is planning, on behalf of the Ministry of Health and Care Services (HOD), to hold an open tender contest for the procurement of vaccines against pandemic influensa for the Norwegian population. The intention of this procurement is to ensure inhabitants in Norway access to the vaccination in the event of pandemic influensa in the contract period.
Vis anskaffelsen » Nevnte leverandører:GlaxoSmithKline ASSeqirus UK Limited